EDGAR Filing Documents for 0000912057-96-030124

Form SB-2 - Optional form for registration of securities to be sold to the public by small business issuers:

SEC Accession No. 0000912057-96-030124

Filing Date

1996-12-24

Accepted

1996-12-24 00:00:00

Documents

SROs

NONE

Document Format Files

Seq	Description	Document	Type	Size
1	SB-2		SB-2	294353
2	EXHIBIT 3.1		EX-3.1	30212
3	EXHIBIT 3.2		EX-3.2	47640
4	EXHIBIT 3.3		EX-3.3	38016
5	EXHIBIT 3.4		EX-3.4	20996
6	EXHIBIT 5		EX-5	2308
7	EXHIBIT 10.1		EX-10.1	18925
8	EXHIBIT 10.2		EX-10.2	11250
9	EXHIBIT 10.3		EX-10.3	18060
10	EX 10.4		EX-10.4	156814
11	EXHIBIT 10.6		EX-10.6	30919
12	EXHIBIT 10.7		EX-10.7	53116
13	EXHIBIT 10.8		EX-10.8	24521
14	EXHIBIT 10.9		EX-10.9	53616
15	EXHIBIT 10.10		EX-10.10	26696
16	EXHIBIT 10.11		EX-10.11	50576
17	EXHIBIT 10.12		EX-10.12	23484
18	EXHIBIT 11		EX-11	1676
19	CONSENT OF INDEPENDENT AUDITORS		EX-23.1	517
20	EXHIBIT 27		EX-27	3323
	Complete submission text file	0000912057-96-030124.txt		910157

Mailing Address ONE KENDALL SQUARE BUILDING 200 SUITE 2200 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BUILDING 200 SUITE 2200 CAMBRIDGE MA 02139 6176217154

APOLLO BIOPHARMACEUTICS INC (Filer) CIK: 0001029495 (see all company filings)